Cerity Partners
DFTX icon

Cerity Partners’s Definium Therapeutics DFTX Stock Holding History

Cerity Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Buy
+53,883
New +$1.33M ﹤0.01% 1461
2025
Q4 		– Sell
-49,650
Closed -$585K – 2969
2025
Q3 		$585K Hold
49,650
– – ﹤0.01% 1876
2025
Q2 		$322K Buy
49,650
+1,165
+2% +$7.66K ﹤0.01% 2118
2025
Q1 		$284K Buy
+48,485
New +$347K ﹤0.01% 2049

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cerity Partners's DFTX Position: Q2 2026 in Review

Cerity Partners opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 53,883 shares worth $2.53M. The stake represents ﹤0.01% of the portfolio and ranks #1461 among its holdings. This is a return to the name: Cerity Partners previously reported a position in DFTX as recently as Q3 2025.

Cerity Partners first reported a position in DFTX in Q1 2025 and has held it in 4 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Cerity Partners held 53,883 shares of Definium Therapeutics worth $2.53M as of Q2 2026.
  • Definium Therapeutics was a new Cerity Partners position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1461 holding.
  • Cerity Partners first reported a position in Definium Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.